Clinical Trial Update: DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients

View source ↗

Summary

A clinical trial investigates how DPP-4 inhibitors may influence cancer-related mechanisms in patients with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DPP-4 inhibitors

Snippet

Sponsor: Nagaoka Red Cross Hospital | Conditions: Type 2 Diabetes Mellitus | Status: UNKNOWN